Nasdaq, Inc. · NDAQ · FY2024 Q4 · Calendar Q1 2025
Nasdaq’s platform strategy gains traction, with execution risks ahead
The supplied analysis supports a constructive but conditional view: demand for cloud, compliance and market infrastructure, together with platform integration, can support growth if execution remains disciplined and regulatory demand persists.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about NDAQ FY2024 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The supplied current-call analysis emphasizes platform integration, cross-selling, AI-enabled product development and geographic expansion as the main growth levers, while highlighting a more cautious set of execution, regulatory and Workflow & Insights risks.
Guidance delta
Management guidance sentiment was maintained; the supplied analysis does not identify a new directional change.
Key takeaways
- The supplied analysis points to resilient demand for cloud, compliance and market-infrastructure products.
- Integration of acquired platforms is intended to support cross-selling and broader product coverage.
- AI-enabled product development and international expansion are central to the growth plan.
- The main counterweights are slower Workflow & Insights growth, regulatory uncertainty and execution costs.
Management priorities
- Expand cloud-based financial-crime, surveillance and regulatory-reporting products
- Build cross-selling across the integrated platform portfolio
- Extend product and market reach internationally, including digital-asset offerings
Follow NDAQ with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Oct 9, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 2, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 24, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 9, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 30, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 30, 2026 |
| UBS | Buy | Buy | Maintain | Jan 12, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 25, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 15, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 2, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 8, 2025 |
| B of A Securities | Buy | Buy | Maintain | Apr 2, 2025 |
| Argus Research | Buy | Buy | Maintain | Nov 5, 2024 |
| Rosenblatt | Neutral | Buy | Downgrade | May 8, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 30, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 14, 2022 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Aug 19, 2022 |
| Loop Capital | Buy | Buy | Maintain | Oct 9, 2020 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 10, 2020 |
| Compass Point | Neutral | Neutral | Maintain | Apr 6, 2020 |
| Bernstein | Perform | Market Perform | Maintain | Apr 10, 2018 |
| Bank of America | Underperform | Underperform | Maintain | Feb 1, 2018 |
| Jefferies | Hold | Hold | Maintain | Jul 17, 2017 |
| CLSA | Buy | Outperform | Maintain | Dec 5, 2016 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Jul 28, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | May 20, 2016 |
| Buckingham Research | Buy | Buy | Maintain | Apr 27, 2016 |
| Portales Partners | Sector Perform | Outperform | Downgrade | Apr 24, 2015 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Jul 14, 2014 |
| Evercore ISI Group | Overweight | Equal Weight | Upgrade | Jul 14, 2014 |
| ISI Group | Neutral | Neutral | Maintain | Feb 12, 2013 |
| Stifel | Buy | Buy | Maintain | Jan 15, 2013 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 13, 2012 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 11, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $93.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Analyst unavailable | $118 | $92.37 | +26.6% | Oct 9, 2026 |
| Piper Sandler | Analyst unavailable | $108 | $91.67 | +15.9% | Oct 2, 2026 |
| Wells Fargo | Analyst unavailable | $100 | $91.67 | +7.3% | Oct 1, 2026 |
| Morgan Stanley | Michael Cyprys | $120 | $91.56 | +28.8% | Jul 24, 2026 |
| Barclays | Analyst unavailable | $111 | $90.42 | +19.1% | Jul 24, 2026 |
| Morgan Stanley | Analyst unavailable | $112 | $88.81 | +20.2% | Jul 10, 2026 |
| Raymond James | Patrick O'Shaughnessy | $113 | $86.1 | +21.2% | Jul 9, 2026 |
| Redburn Partners | Simon Clinch | $110 | $86.72 | +18.0% | Jun 11, 2026 |
| Loop Capital Markets | Analyst unavailable | $113 | $87.04 | +21.2% | Apr 24, 2026 |
| Raymond James | Patrick O\'Shaughnessy | $109 | $83.99 | +17.0% | Feb 25, 2026 |
| Morgan Stanley | Michael Cyprys | $116 | $98.42 | +24.5% | Jan 30, 2026 |
| Morgan Stanley | Analyst unavailable | $113 | $100.91 | +21.2% | Jan 15, 2026 |
| UBS | Alex Kramm | $120 | $99.37 | +28.8% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $115 | $100.4 | +23.4% | Jan 8, 2026 |
| Morgan Stanley | Analyst unavailable | $111 | $95.36 | +19.1% | Dec 22, 2025 |
| Barclays | Analyst unavailable | $114 | $93.86 | +22.3% | Dec 12, 2025 |
| Morgan Stanley | Analyst unavailable | $110 | $86.02 | +18.0% | Nov 20, 2025 |
| Barclays | Benjamin Budish | $109 | $90.33 | +17.0% | Oct 22, 2025 |
| Raymond James | Patrick O'Shaughnessy | $100 | $88.9 | +7.3% | Oct 13, 2025 |
| RBC Capital | Analyst unavailable | $108 | $90.14 | +15.9% | Oct 9, 2025 |
| Barclays | Benjamin Budish | $108 | $88.44 | +15.9% | Oct 8, 2025 |
| Morgan Stanley | Analyst unavailable | $90 | $87.1 | -3.4% | Oct 1, 2025 |
| Raymond James | Patrick O'Shaughnessy | $96 | $89.58 | +3.0% | Jul 9, 2025 |
| Oppenheimer | Owen Lau | $96 | $85.95 | +3.0% | Jun 17, 2025 |
| Raymond James | Patrick O'Shaughnessy | $84 | $76.36 | -9.9% | Jan 9, 2025 |
| Raymond James | Patrick O'Shaughnessy | $82 | $71.62 | -12.0% | Oct 14, 2024 |
| RBC Capital | Ashish Sabadra | $88 | $72.56 | -5.6% | Sep 26, 2024 |
| Morgan Stanley | Joseph Moore | $55 | $73.51 | -41.0% | Sep 4, 2024 |
| Bank of America Securities | Craig Siegenthaler | $90 | $71.39 | -3.4% | Sep 4, 2024 |
| Oppenheimer | Owen Lau | $78 | $69.15 | -16.3% | Jul 30, 2024 |
| Argus Research | Kevin Heal | $66 | $60.62 | -29.2% | May 14, 2024 |
| Oppenheimer | Owen Lau | $72 | $63.06 | -22.7% | Apr 12, 2024 |
| Barclays | Benjamin Budish | $76 | $63.01 | -18.5% | Apr 11, 2024 |
| Morgan Stanley | Michael Cyprys | $80 | $62.14 | -14.2% | Apr 9, 2024 |
| Deutsche Bank | Brian Bedell | $60 | $61.06 | -35.6% | Apr 5, 2024 |
| Goldman Sachs | Alexander Blostein | $73 | $61.06 | -21.7% | Mar 26, 2024 |
| Rosenblatt Securities | Andrew Bond | $82 | $51.29 | -12.0% | Oct 19, 2023 |
| Oppenheimer | Owen Lau | $65 | $51.02 | -30.3% | Jun 13, 2023 |
| Morgan Stanley | Michael Cyprys | $60 | $54.52 | -35.6% | Apr 11, 2023 |
| Credit Suisse | Gautam Sawant | $57 | $62.35 | -38.8% | Nov 2, 2022 |
| Deutsche Bank | Brian Bedell | $61.33 | $48.71 | -34.2% | May 23, 2022 |
| Deutsche Bank | Brian Bedell | $69 | $54.59 | -26.0% | Apr 26, 2022 |
| Morgan Stanley | Analyst unavailable | $79.67 | $57.47 | -14.5% | Apr 21, 2022 |
| Rosenblatt Securities | Analyst unavailable | $68 | $57.6 | -27.0% | Apr 21, 2022 |
| Rosenblatt Securities | Sean Horgan | $66.67 | $55.49 | -28.5% | Mar 10, 2022 |
| Deutsche Bank | Brian Bedell | $70 | $57.18 | -24.9% | Feb 21, 2022 |
| Deutsche Bank | Brian Bedell | $79 | $62.05 | -15.2% | Jan 17, 2022 |
| Jefferies | Daniel Fannon | $63 | $62.84 | -32.4% | Jan 10, 2022 |
| Goldman Sachs | Alexander Blostein | $63.33 | $67.27 | -32.0% | Jan 3, 2022 |
| Piper Sandler | Richard Repetto | $73.33 | $67.85 | -21.3% | Dec 22, 2021 |
| Atlantic Equities | Simon Clinch | $73.33 | $64.8 | -21.3% | Sep 14, 2021 |
| Compass Point | Christopher Allen | $65 | $61.25 | -30.3% | Jul 22, 2021 |
| Barclays | Jeremy Campbell | $58.33 | $52.61 | -37.4% | Apr 22, 2021 |
| Wells Fargo | Christopher Harris | $62 | $52.61 | -33.5% | Apr 22, 2021 |
Track every rating change on NDAQ the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNasdaq, Inc., a technology powerhouse founded in 1971 and based in New York City, is dedicated to supporting capital markets and various other sectors worldwide. Its Market Technology division specializes in fighting financial crime, offering products like Nasdaq Trade Surveillance, a SaaS solution that assists brokers and market participants in meeting compliance requirements and internal surveillance policies. This segment also provides Nasdaq Automated Investigator, a cloud-deployed anti-money laundering tool, and Verafin, a SaaS provider for anti-financial crime management. Furthermore, this division handles a wide array of assets, including cash equities, equity derivatives, global currencies, interest-bearing securities, commodities, energy resources, and digital currencies. The Investment Intelligence segment is responsible for distributing both historical and live market data, creating and licensing Nasdaq-branded financial indexes and products, and delivering valuable investment insights and workflow solutions.…
Historical context
All NDAQ earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FITB Fifth Third Bancorp | FY2026 Q3 · Calendar Q4 2026 | +36.0% | +0.3% | Fifth Third completes Comerica integration as deposits and efficiency improve |
| IBN ICICI Bank Limited | FY2027 Q2 · Calendar Q4 2026 | +1.0% | — | ICICI Bank sustains strong growth, but funding weighs on margins |
| HDB HDFC Bank Limited | FY2027 Q2 · Calendar Q4 2026 | -2.0% | — | HDFC Bank: Strong deposits and asset quality, margins under pressure |
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T Bank: Loan Growth Holds Up as Rates Pressure Margins |
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | +2.2% | — | M&T: Deposit growth supports margins as AI use expands |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | +10.3% | — | Regions Financial: Fee Growth and Credit Quality Support Q3 |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the NDAQ recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-01-15T00:03:22.707476+00:00
- Polygon adjusted daily market bars · 2026-10-20T09:30:45.070139+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T09:30:45.066670+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.